Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
5.16
-0.07 (-1.34%)
At close: Oct 23, 2025, 4:00 PM EDT
5.16
0.00 (0.00%)
After-hours: Oct 23, 2025, 7:02 PM EDT

Tvardi Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover Tvardi Therapeutics stock have a consensus rating of "Buy" and an average price target of $51.67, which forecasts a 901.36% increase in the stock price over the next year. The lowest target is $15 and the highest is $78.

Price Target: $51.67 (+901.36%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$15$51.67$61$78
Change+190.70%+901.36%+1082.2%+1411.6%

Analyst Ratings

The average analyst rating for Tvardi Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy111112
Buy124444
Hold000001
Sell000000
Strong Sell000000
Total235557

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Raymond James
Raymond James
Hold
Downgrades
n/a
HoldDowngradesn/an/aOct 14, 2025
BTIG
BTIG
Strong Buy
Maintains
$55$15
Strong BuyMaintains$55$15+190.70%Oct 13, 2025
Barclays
Barclays
Buy
Initiates
$61
BuyInitiates$61+1,082.17%Oct 13, 2025
Raymond James
Raymond James
Buy
Initiates
$62
BuyInitiates$62+1,101.55%Jul 14, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$52
BuyInitiates$52+907.75%Jul 11, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
530.40K
Revenue Next Year
n/a
from 530.40K
EPS This Year
-2.82
from -4.59
EPS Next Year
-3.91
from -2.82
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
---530.40K--
Revenue Growth
------
EPS
-3.22-2.72-4.59-2.82-3.91-5.68
EPS Growth
------
Forward PE
------
No. Analysts
---998
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High2.7Mn/a
Avg530,400n/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027
High--
Avg--
Low--

EPS Forecast

EPS202520262027
High-2.46-1.49
Avg-2.82-3.91
Low-3.36-5.60

EPS Growth

EPS Growth202520262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.